Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
City rallies behind EMIS
Analyst support is growing for healthcare software supplier EMIS (EMIS:AIM) with consensus implying 100p upside to the 836p share price over the next 12 months. The shares are down 26% this year on NHS cutbacks but the need for IT systems to create the faster, better, cheaper care required looks as strong as ever. N+1 Singer believes the stock could hit £12.50 if a buyer emerges. (SF)